Cargando…
Assessment of Awareness Levels About Anticoagulants in Patients With Atrial Fibrillation Presenting to Emergency Department
Atrial fibrillation (AF) is a rhythm disorder observed mostly amongst adults. AF has been regarded as one of the most important medical problems because it leads to thromboembolism and paralysis risks. Although warfarin has been used in the past to cope with this health problem, new oral anticoagula...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912972/ https://www.ncbi.nlm.nih.gov/pubmed/33654628 http://dx.doi.org/10.7759/cureus.12963 |
_version_ | 1783656697932283904 |
---|---|
author | Akman, Canan Kırılmaz, Bahadır Balcı, Serdal Aksit, Ercan Yurtseven, Ersan Duygu, Ali |
author_facet | Akman, Canan Kırılmaz, Bahadır Balcı, Serdal Aksit, Ercan Yurtseven, Ersan Duygu, Ali |
author_sort | Akman, Canan |
collection | PubMed |
description | Atrial fibrillation (AF) is a rhythm disorder observed mostly amongst adults. AF has been regarded as one of the most important medical problems because it leads to thromboembolism and paralysis risks. Although warfarin has been used in the past to cope with this health problem, new oral anticoagulant medicines have replaced it in the last few years. The new oral anticoagulants, namely, dabigatran etexilate, rivaroxaban, and apixaban, are currently being used in daily clinical practice and treatment guidelines. Since AF patients are supposed to receive long-term oral anticoagulant therapy, it is extremely important to provide them with accurate information and appropriate training regarding the treatment to decrease oncoming complications. This is a prospective study involving 168 patients who were admitted to the emergency department with AF and who were using oral anticoagulants. Findings indicate a lack of awareness in the patients regarding the effects and side effects of the drugs they take despite having been informed by the prescribing physician. We believe that informed action by patients with regard to the oral anticoagulants and their side effects will have an impact on the reduction in hospitalization observed. It will also make a substantial contribution to the quality of life of AF patients and to their use of medical services. |
format | Online Article Text |
id | pubmed-7912972 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-79129722021-03-01 Assessment of Awareness Levels About Anticoagulants in Patients With Atrial Fibrillation Presenting to Emergency Department Akman, Canan Kırılmaz, Bahadır Balcı, Serdal Aksit, Ercan Yurtseven, Ersan Duygu, Ali Cureus Cardiology Atrial fibrillation (AF) is a rhythm disorder observed mostly amongst adults. AF has been regarded as one of the most important medical problems because it leads to thromboembolism and paralysis risks. Although warfarin has been used in the past to cope with this health problem, new oral anticoagulant medicines have replaced it in the last few years. The new oral anticoagulants, namely, dabigatran etexilate, rivaroxaban, and apixaban, are currently being used in daily clinical practice and treatment guidelines. Since AF patients are supposed to receive long-term oral anticoagulant therapy, it is extremely important to provide them with accurate information and appropriate training regarding the treatment to decrease oncoming complications. This is a prospective study involving 168 patients who were admitted to the emergency department with AF and who were using oral anticoagulants. Findings indicate a lack of awareness in the patients regarding the effects and side effects of the drugs they take despite having been informed by the prescribing physician. We believe that informed action by patients with regard to the oral anticoagulants and their side effects will have an impact on the reduction in hospitalization observed. It will also make a substantial contribution to the quality of life of AF patients and to their use of medical services. Cureus 2021-01-28 /pmc/articles/PMC7912972/ /pubmed/33654628 http://dx.doi.org/10.7759/cureus.12963 Text en Copyright © 2021, Akman et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Cardiology Akman, Canan Kırılmaz, Bahadır Balcı, Serdal Aksit, Ercan Yurtseven, Ersan Duygu, Ali Assessment of Awareness Levels About Anticoagulants in Patients With Atrial Fibrillation Presenting to Emergency Department |
title | Assessment of Awareness Levels About Anticoagulants in Patients With Atrial Fibrillation Presenting to Emergency Department |
title_full | Assessment of Awareness Levels About Anticoagulants in Patients With Atrial Fibrillation Presenting to Emergency Department |
title_fullStr | Assessment of Awareness Levels About Anticoagulants in Patients With Atrial Fibrillation Presenting to Emergency Department |
title_full_unstemmed | Assessment of Awareness Levels About Anticoagulants in Patients With Atrial Fibrillation Presenting to Emergency Department |
title_short | Assessment of Awareness Levels About Anticoagulants in Patients With Atrial Fibrillation Presenting to Emergency Department |
title_sort | assessment of awareness levels about anticoagulants in patients with atrial fibrillation presenting to emergency department |
topic | Cardiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912972/ https://www.ncbi.nlm.nih.gov/pubmed/33654628 http://dx.doi.org/10.7759/cureus.12963 |
work_keys_str_mv | AT akmancanan assessmentofawarenesslevelsaboutanticoagulantsinpatientswithatrialfibrillationpresentingtoemergencydepartment AT kırılmazbahadır assessmentofawarenesslevelsaboutanticoagulantsinpatientswithatrialfibrillationpresentingtoemergencydepartment AT balcıserdal assessmentofawarenesslevelsaboutanticoagulantsinpatientswithatrialfibrillationpresentingtoemergencydepartment AT aksitercan assessmentofawarenesslevelsaboutanticoagulantsinpatientswithatrialfibrillationpresentingtoemergencydepartment AT yurtsevenersan assessmentofawarenesslevelsaboutanticoagulantsinpatientswithatrialfibrillationpresentingtoemergencydepartment AT duyguali assessmentofawarenesslevelsaboutanticoagulantsinpatientswithatrialfibrillationpresentingtoemergencydepartment |